Pioglitazone 30 mg  Tablets 

Composit uses/ indication of PIGMA-30 :

Diabetes mellitus type 2 in monotherapy and in combination with a sulfonylurea, metformin, or insulin.

Composit contra indication of PIGMA-30 :

Known hypersensitivity to pioglitazone, diabetes mellitus type 1 and diabetic ketoacidosis. Pregnancy, lactation (breastfeeding) and people under 18.

Pharyngitis, oedema, headache, upper respiratory tract infection, sinusitis, anaemia, GI disturbances, weight gain, visual disturbances, dizziness, arthralgia, haematuria, impotence.

Increased risk of hypoglycaemia when used with insulin or oral hypoglycaemics. Oedema, congestive heart failure, hepatic dysfunction, jaundice, anaemia. May cause ovulation in premenopausal, anovulatory women. Monitor liver function before and during treatment. Monitor glycaemic control.

Pioglitazone 30 mg  Tablets 

Composit uses/ indication of PIGMA-30 :

Diabetes mellitus type 2 in monotherapy and in combination with a sulfonylurea, metformin, or insulin.

Composit contra indication of PIGMA-30 :

Known hypersensitivity to pioglitazone, diabetes mellitus type 1 and diabetic ketoacidosis. Pregnancy, lactation (breastfeeding) and people under 18.

Pharyngitis, oedema, headache, upper respiratory tract infection, sinusitis, anaemia, GI disturbances, weight gain, visual disturbances, dizziness, arthralgia, haematuria, impotence.

Increased risk of hypoglycaemia when used with insulin or oral hypoglycaemics. Oedema, congestive heart failure, hepatic dysfunction, jaundice, anaemia. May cause ovulation in premenopausal, anovulatory women. Monitor liver function before and during treatment. Monitor glycaemic control.